Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
Clinical Drug Investigation
|
February 27, 2022
Correction to: Efficacy and Safety Results from a Phase 2, Randomized, Double Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma
Baek-Yeol Ryoo, Daniel H Palmer, Sook Ryun Park, et al.
Clinical Drug Investigation
|
August 5, 2021
Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma
Baek-Yeol Ryoo, Daniel H Palmer, Sook Ryun Park, et al.
Journal of Intellectual & Developmental Disability
|
January 16, 2025
Preconditions influencing the development of post-secondary training programs in universities for individuals with intellectual disabilities
Denise De Souza, Zelinna Pablo, Michael Shevlin, et al.
BMC Cancer
|
January 20, 2025
Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2
Hemant M Kocher, , , et al.
Advances in Therapy
|
April 6, 2021
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison
Jörg Trojan, Patrick Mollon, Bruno Daniele, et al.
Journal of Neuroendocrinology
|
March 12, 2024
Neuroendocrine neoplasms: Consensus on a patient care pathway
Jessica Hooper, Nikie Jervis, Lucy Morgan, et al.
Journal of Neuroendocrinology
|
February 23, 2024
The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours
Dominique S V M Clement, Monique E van Leerdam, Margot E T Tesselaar, et al.
Cancer Chemotherapy and Pharmacology
|
August 9, 2018
A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
Mary E R O'Brien, Debashis Sarker, Jaishree Bhosle, et al.
Frontiers in Oncology
|
March 19, 2020
Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study
Sam Sollie, Aida Santaolalla, Dominique S Michaud, et al.
European Journal of Gastroenterology & Hepatology
|
September 14, 2016
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problem
Dimitrios C Ziogas, Dionysios Papadatos-Pastos, Kiruthikah Thillai, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
Clinical Drug Investigation
|
February 27, 2022
Correction to: Efficacy and Safety Results from a Phase 2, Randomized, Double Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma
Baek-Yeol Ryoo, Daniel H Palmer, Sook Ryun Park, et al.
Clinical Drug Investigation
|
August 5, 2021
Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma
Baek-Yeol Ryoo, Daniel H Palmer, Sook Ryun Park, et al.
Journal of Intellectual & Developmental Disability
|
January 16, 2025
Preconditions influencing the development of post-secondary training programs in universities for individuals with intellectual disabilities
Denise De Souza, Zelinna Pablo, Michael Shevlin, et al.
BMC Cancer
|
January 20, 2025
Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2
Hemant M Kocher, , , et al.
Advances in Therapy
|
April 6, 2021
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison
Jörg Trojan, Patrick Mollon, Bruno Daniele, et al.
Journal of Neuroendocrinology
|
March 12, 2024
Neuroendocrine neoplasms: Consensus on a patient care pathway
Jessica Hooper, Nikie Jervis, Lucy Morgan, et al.
Journal of Neuroendocrinology
|
February 23, 2024
The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours
Dominique S V M Clement, Monique E van Leerdam, Margot E T Tesselaar, et al.
Cancer Chemotherapy and Pharmacology
|
August 9, 2018
A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
Mary E R O'Brien, Debashis Sarker, Jaishree Bhosle, et al.
Frontiers in Oncology
|
March 19, 2020
Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study
Sam Sollie, Aida Santaolalla, Dominique S Michaud, et al.
European Journal of Gastroenterology & Hepatology
|
September 14, 2016
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problem
Dimitrios C Ziogas, Dionysios Papadatos-Pastos, Kiruthikah Thillai, et al.
Page
of 8